Clinching his 5th gold medal in Standard Chartered Marathon Singapore, the SEA Games marathon gold medalist, Mok Ying Ren, has leaped ahead on his Road to Rio 2016. His eyes are set on his next mark – SEA Games 2015, and thereafter, he is planning a more intensive training stint overseas. It is certain that Mok’s road ahead is lined with rigorous training and he is taking measures to stay as injury-free as possible throughout this crucial period.
Singapore football legend Fandi Ahmad carries a surprising amount of grooming products in his carryall.
There are full-sized bottles of skincare products - cleanser, toner, moisturiser and eye cream - from Lab Series; a full-sized bottle of Dove shower cream; a Gillette shaver and shaving cream; and a bottle of Abercrombie & Fitch cologne.
"I guess that's why I still look good at 52," says the Lions XII coach, cheekily.
But the facial hair he is currently sporting has nothing to do with vanity or some hipster trend.
For the past month, he has been growing out a moustache and beard as the ambassador of the annual charity initiative Movember.
The initiative encourages men to keep moustaches for a month in November to raise funds and awareness of men’s health issues, such as prostate and testicular cancer.
Throughout his football career, local legend, Fandi Ahmad, 52, endured much pain due to injuries. They can be injuries due to over-usage of his joints coupled with normal wear and tear of joint cartilage, muscle injuries or tendon and ligament injuries. As his age progressed, his knees problems became more pronounced.
In early July, Fandi was introduced to a UK product called FLEXISEQ. This gel works by delivering lubricant into the joint. Considering that it is easy to use (by applying it topically) and that it does not contain any drug or medication, it became an interesting proposition for Fandi because, unlike injections, he will not have any treatment downtime, and being drug-free, he does not have to worry about drug testing when using FLEXISEQ.
He brought along a few tubes and started using it during his training stint in Austria. When he returned, he found that there was less 'cracking' in his knees and his pain had been reduced greatly. At least, he could last longer in the field now; he could run and dribble the ball for a longer time than before when coaching.
Listen to the audio clip below as Dr. Chiam and Fandi Ahmad talk about sports injury and joint pain.
Together with increasing age and long period of exercising, our joints undergo a lot of wearing down, or even sporting injuries that can lead to pain in the joint areas.
Dr Chiam Tut Fu from Pacific Healthcare Specialist Centre has over 20 years of experience in treating sporting injuries. He said that the most common forms of sports-related injuries are more common amongst those who do a lot of running and jumping. This causes increased friction within the joints, wearing down of the cartilage, and inflammation of the joints that can result in pain.
The common forms of treatments include lower frequency of exercise, anti-inflammatory drugs, synovial fluid injections, injections of platelet-containing plasma, or surgeries.
Soccer legend Fandi Ahmad is already 52 this year. Years of soccer training coupled with advancing age has led Fandi to face a problem that afflicts most middle-aged – joint problems.
Fandi has shared that he has gone through 10 operations due to sports injuries, with the most serious being a muscle tear in his right leg. He was training in Holland at that time, and had to rest two and a half months before starting to recover.
The current LionsXII coach revealed that from 45 onwards, he started to feel discomfort in his joints. This typically happened during exercise where he experienced hardening and pain in some parts of his body.
Leicester Tigers are the most successful rugby union side in England who have won their league a record 10 times since 1987. Leicester are also the only English side to have qualified to play in every Heineken Cup in which English teams have participated, and are also the most successful English side in Europe
The Tigers are supported by a world class sports medicine department who constantly strive to maintain the players in peak physical condition and when injuries inevitably occur, aim to make them stronger, better and less injury prone than before.
FLEXISEQ are proud to supply the Leicester Tigers medical staff, to help look after the joints of the athletes under their care.
A while ago, Fandi Ahmad could only be out for 45 minutes with the veteran team represented Singapore. But two months ago, the coach of LionsXII and the public’s favourite player was able to last 90 minutes!
So, what’s the secret?
“I was introduced to Flexiseq, a cream that I apply on my knees. Since then, I could feel the difference in my knees,” he said at the Flexiseq launch yesterday.
28th January 2014, London: Pro Bono Bio®, the global leader in nano-physical healthcare products, announces the UK national launch of FLEXISEQ™, the innovative drug-free, safe treatment for joint pain associated with osteoarthritis1 (OA) following the successful conclusion of the pioneering 2 month Charity partnership phase for the benefit of Arthritis Research UK. The contribution in products that are sold through the Arthritis Research UK website and through LloydsPharmacy has raised over £400,000 for the medical research charity. Sufferers have enthusiastically welcomed the new, effective and safe product that they can self-medicate and it is now going on sale through all leading pharmacies in the
UK. FLEXISEQ comes with significant advantages as the product has no contra-indications, contains no drugs so cannot cause drug-to-drug interactions and so is safer than the existing drug treatments.
3rd December 2013, London: Pro Bono Bio®, the global leader in nano-physical healthcare products, announces the UK Charity launch of FLEXISEQ™, the innovative drug-free, safe treatment for joint pain associated with osteoarthritis₁ (OA). FLEXISEQ’s proven efficacy comes with significant advantages as the product has no contra-indications, contains no drugs so cannot cause drug-to-drug interactions, and with over 6 million doses administered since launch there have been no reported systemic side effects.
FLEXISEQ is already successfully sold in the early pilot markets of Austria, Germany, Ireland, Malaysia and Singapore. Earlier this year, FLEXISEQ won the Innovation Award 2013 from the Federal Association of German Pharmacists. In June, FLEXISEQ launched in Ireland and became the fastest growing over-the-counter product that pharmacies there had seen in recent times.
It was a weird invite for me to get, a medical device press luncheon. I did email the pr company back who invited me explaining that this was not in my realm of writing but I would love to accept the invite if that offer still stood. Frankly I think they made a mistake and was hoping I'd decline; but considering my autoimmune disease there was no way I was missing the opportunity!
Flexiseq is a new topical gel targeting pain in osteoarthritis sufferers. You may know that since suffering through chikungunya in 2008 I am now laden with a reactive arthritis in my hips, wrists and ankles. I take a lot of pills twice daily.
October 2013 – FLEXISEQ, the award winning new drug-free treatment for Osteoarthritis is now available in Singapore. Clinically proven* in Europe to be as effective at pain relief as the prescription drug celecoxib, but with an excellent safety profile, Flexiseq has been hailed in Europe as a Wondergel*. Flexiseq has already won The Innovation Award 2013 from the Federal Association of German Pharmacists for its break through Nano Technology.
Berlin 25.1013 "Get people moving – experience success". This slogan of the German Congress of Orthopaedics and Trauma Surgery also held true for the symposium organised by Pro Bono Bio, which reported on a new, innovative and award-winning therapy option for osteoarthritis patients. Studies were presented proving the efficacy of the topical gel for pain and joint stiffness associated with osteoarthritis as well as personal experiences of the presenters with FLEXISEQ™ based on patient cases. FLEXISEQ contains no pharmacologically active substances, but works through the use of Sequessome™ vesicles, tiny phospholipid droplets that penetrate the skin into the joint and lubricate the damaged cartilage. Worldwide marketing of the gel, developed and produced in Germany, is pending after initial successes in Europe and Asia, as company head John Mayo reported.
555 patient clinical trial provides further evidence that FLEXISEQ is effective in reducing pain for osteoarthritis patients with a particularly strong safety profile.
London, England 6 September 2013 –Key clinical trial data supporting Pro Bono Bio’s (“PBB”) drug-free osteoarthritis treatment FLEXISEQ, have been published in The Journal of Rheumatology. This is the latest high profile publication after winning the German Pharmacy Industry award for innovation in January 2013.
The publication reports that FLEXISEQ (TDT 064) was very effective in managing the pain associated with osteoarthritis (OA) and was again found to have a much stronger safety profile than other treatments.
Dr Matthias Rother, lead author of the publication, said: ‘This is an important study which further confirms the safety and efficacy of FLEXISEQ for treatment of the chronic pain and stiffness that troubles so many patients with OA. The effect size seen here for FLEXISEQ is comparable to the effect sizes seen in a comparative study using the same design which demonstrated that FLEXISEQ has equivalent efficacy to the widely used oral NSAID, celecoxib. That study was published in “Rheumatology” earlier this year (Conaghan et 2013). These two studies are among several which consistently demonstrate the benefits of this drug-free gel.’
KUALA LUMPUR: FARMASIA Sdn Bhd and Pro Bono Bio recently handed over pain relief gel Flexiseq to Lembaga Tabung Haji for pilgrims performing their haj this year.
The donation is a continuation of Farmasia's CSR activities after the company's first donation of Flexiseq to Malaysian pilgrims in November last year.
For Pro Bono Bio, this donation is part of the company's humanitarian mission and follows its donation of Flexiseq to the haj pilgrims of Senegal last year.
"We have decided to continue this initiative due to the positive response we received from last year's pilgrims who used the gel.
"According to the pilgrims, applying the gel significantly eased the pain caused by osteoarthritis in their knees and that helped them tremendously with their journey,"said Farmasia Sdn Bhd director Zohrah Al-Aidruss.
Kuala Lumpur & London August 1, 2013 - FARMASIA Sdn Bhd and Pro Bono Bio donated FLEXISEQ™ Gel to Lembaga Tabung Haji for pilgrims performing their Hajj this year. The donation was acknowledged during a ceremony held at the Lembaga Tabung Haji Headquarters in Kuala Lumpur today. The event was attended by YBhg Dato’ Seri Jamil Khir Bin Baharom, Minister in the Prime Minister’s Department, the Chairman of Lembaga Tabung Haji, YBhg Datuk Haji Abdul Azeez Bin Abdul Rahim, and it’s Chief Executive Officer, YBhg Dato’ Paduka Ismee Ismail.
FLEXISEQ has also been purchased by Tabung Haji and will form part of the medical team’s treatment regime for pilgrims suffering from OA during their Hajj. This purchase, which comes very soon after the product’s introduction into Malaysia, is a sign of the overall confidence in the product’s benefit.
Besides Tabung Haji, several other institutions and foundations have purchased FLEXISEQ for their pilgrims, with several more showing keen interest in its benefits. This will ensure that a total of over 7,000 Malaysian pilgrims will benefit from FLEXISEQ during the Hajj this year.
All rights reserved.